Biosimilars or semi-similars?
Crossref DOI link: https://doi.org/10.1038/nbt.3083
Published Online: 2015-01-09
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schellekens, Huub
Moors, Ellen
Text and Data Mining valid from 2015-01-01
Article History
First Online: 9 January 2015
Competing interests
: H.S. is a member of the advisory boards on biosimilars of Amgen, Pfizer and Merck-Serono.